Skip to content
Home/Companies/Biotech/lophius

lophius

Biotech·Germany·Exited 2021·Held 5yr
Entry
2016
Hold
5yr
Exit
2021

Who owns lophius?

lophius was owned by Sobera Capital through S-Refit AG (2016 vintage) from 2016 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-10

Sobera Capital
Investor
Sobera Capital
S-Refit AG · 2016 · Secondaries

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from S-Refit AG

Other portfolio companies in the same fund.

Amicra
Exited 2018
Deep TechGermany· 2016
to
BioMAX
Exited 2022
HealthTechGermany· 2016
Curadis
Active
BiotechGermany· 2016
EnOcean
EnOcean
Exited 2024
Deep TechGermany· 2016
ERS electronic
Exited 2023
IndustrialsGermany· 2016
to
Isarna
Isarna
Active
BiotechGermany· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track lophius

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on lophius.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue